Average Co-Inventor Count = 13.26
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (7 from 3,923 patents)
2. University of Pennsylvania (7 from 2,620 patents)
7 patents:
1. 12344657 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
2. RE49847 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
3. 11872249 - Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain
4. 11149076 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
5. 11026976 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
6. 10525083 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
7. 10253086 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell